Daniel Robinson
Papers
1
Total Citations
14
H-Index
1
About
Dr. Daniel Robinson is a surgical oncologist whose research focuses on the management of rare hepatic tumors and the application of ablative therapies in complex clinical scenarios. His work addresses critical gaps in the treatment of ultra-rare malignancies, particularly primary hepatic epithelioid hemangioendothelioma (HEHE), a vascular tumor with an incidence of less than 0.1 per 100,000 population. In his most cited paper (2018, 14 citations), Dr. Robinson reported on a 70-year-old patient with concurrent renal cell carcinoma and a solitary 10 mm HEHE lesion, demonstrating the feasibility and role of ablative therapy in borderline surgical candidates. This contribution provides valuable guidance for clinicians navigating the intersection of incidental rare tumors and minimally invasive treatment strategies. Dr. Robinson’s work is notable for its focus on individualized, evidence-based approaches to tumors where standardized protocols are lacking. His research continues to inform surgical decision-making for patients with exceptional presentations, bridging the gap between oncologic principles and the practical realities of managing rare diseases.
Research Focus
Key Achievements
Top Papers
- 1